TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer

Clinical trial NCT03720431 · UNKNOWN

Trial details

NCT number: NCT03720431
Sponsor: PharmAbcine
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Triple Negative Breast Cancer

Start date: 2019-01-03
Primary completion: 2020-03-18
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.